Literature DB >> 30252533

Urinary concentrating defect in mice lacking Epac1 or Epac2.

Alena Cherezova1, Viktor Tomilin2, Vadym Buncha1, Oleg Zaika2, Pablo A Ortiz3, Fang Mei2, Xiaodong Cheng2,4, Mykola Mamenko1, Oleh Pochynyuk2.   

Abstract

cAMP is a universal second messenger regulating a plethora of processes in the kidney. Two downstream effectors of cAMP are PKA and exchange protein directly activated by cAMP (Epac), which, unlike PKA, is often linked to elevation of [Ca2+]i. While both Epac isoforms (Epac1 and Epac2) are expressed along the nephron, their relevance in the kidney remains obscure. We combined ratiometric calcium imaging with quantitative immunoblotting, immunofluorescent confocal microscopy, and balance studies in mice lacking Epac1 or Epac2 to determine the role of Epac in renal water-solute handling. Epac1-/- and Epac2-/- mice developed polyuria despite elevated arginine vasopressin levels. We did not detect major deficiencies in arginine vasopressin [Ca2+]i signaling in split-opened collecting ducts or decreases in aquaporin water channel type 2 levels. Instead, sodium-hydrogen exchanger type 3 levels in the proximal tubule were dramatically reduced in Epac1-/- and Epac2-/- mice. Water deprivation revealed persisting polyuria, impaired urinary concentration ability, and augmented urinary excretion of Na+ and urea in both mutant mice. In summary, we report a nonredundant contribution of Epac isoforms to renal function. Deletion of Epac1 and Epac2 decreases sodium-hydrogen exchanger type 3 expression in the proximal tubule, leading to polyuria and osmotic diuresis.-Cherezova, A., Tomilin, V., Buncha, V., Zaika, O., Ortiz, P. A., Mei, F., Cheng, X., Mamenko, M., Pochynyuk, O. Urinary concentrating defect in mice lacking Epac1 or Epac2.

Entities:  

Keywords:  AQP2; NHE-3; collecting duct; urea; water deprivation

Mesh:

Substances:

Year:  2018        PMID: 30252533      PMCID: PMC6338637          DOI: 10.1096/fj.201800435R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.834


  64 in total

1.  Short-term stimulation of the renal Na-K-Cl cotransporter (NKCC2) by vasopressin involves phosphorylation and membrane translocation of the protein.

Authors:  Ignacio Giménez; Biff Forbush
Journal:  J Biol Chem       Date:  2003-05-05       Impact factor: 5.157

Review 2.  NHE3 regulatory complexes.

Authors:  Mark Donowitz; Sachin Mohan; Cindy Xinjun Zhu; Tian-E Chen; Rong Lin; Boyoung Cha; Nicholas C Zachos; Rakhilya Murtazina; Rafiquel Sarker; Xuhang Li
Journal:  J Exp Biol       Date:  2009-06       Impact factor: 3.312

Review 3.  Thick ascending limb of the loop of Henle.

Authors:  David B Mount
Journal:  Clin J Am Soc Nephrol       Date:  2014-10-15       Impact factor: 8.237

4.  Adenylate cyclase-coupled vasopressin receptor activates AQP2 promoter via a dual effect on CRE and AP1 elements.

Authors:  M Yasui; S M Zelenin; G Celsi; A Aperia
Journal:  Am J Physiol       Date:  1997-04

5.  TRPV4 dysfunction promotes renal cystogenesis in autosomal recessive polycystic kidney disease.

Authors:  Oleg Zaika; Mykola Mamenko; Jonathan Berrout; Nabila Boukelmoune; Roger G O'Neil; Oleh Pochynyuk
Journal:  J Am Soc Nephrol       Date:  2013-02-14       Impact factor: 10.121

6.  Epac regulates UT-A1 to increase urea transport in inner medullary collecting ducts.

Authors:  Yanhua Wang; Janet D Klein; Mitsi A Blount; Christopher F Martin; Kimilia J Kent; Vladimir Pech; Susan M Wall; Jeff M Sands
Journal:  J Am Soc Nephrol       Date:  2009-08-06       Impact factor: 10.121

7.  Renal tubular NHE3 is required in the maintenance of water and sodium chloride homeostasis.

Authors:  Robert A Fenton; Søren B Poulsen; Samantha de la Mora Chavez; Manoocher Soleimani; Jessica A Dominguez Rieg; Timo Rieg
Journal:  Kidney Int       Date:  2017-04-03       Impact factor: 10.612

8.  cAMP-binding protein Epac induces cardiomyocyte hypertrophy.

Authors:  Eric Morel; Andrea Marcantoni; Monique Gastineau; Rikke Birkedal; Francesca Rochais; Anne Garnier; Anne-Marie Lompré; Grégoire Vandecasteele; Frank Lezoualc'h
Journal:  Circ Res       Date:  2005-11-03       Impact factor: 17.367

Review 9.  Epac: defining a new mechanism for cAMP action.

Authors:  Martijn Gloerich; Johannes L Bos
Journal:  Annu Rev Pharmacol Toxicol       Date:  2010       Impact factor: 13.820

10.  Reduced NHE3-mediated Na+ absorption increases survival and decreases the incidence of intestinal obstructions in cystic fibrosis mice.

Authors:  Emily M Bradford; Maureen A Sartor; Lara R Gawenis; Lane L Clarke; Gary E Shull
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-01-22       Impact factor: 4.052

View more
  5 in total

1.  TRPV4 deletion protects against hypokalemia during systemic K+ deficiency.

Authors:  Viktor Tomilin; Mykola Mamenko; Oleg Zaika; Charles S Wingo; Oleh Pochynyuk
Journal:  Am J Physiol Renal Physiol       Date:  2019-03-06

2.  A peek into Epac physiology in the kidney.

Authors:  Viktor N Tomilin; Oleh Pochynyuk
Journal:  Am J Physiol Renal Physiol       Date:  2019-09-11

3.  Epac1-/- and Epac2-/- mice exhibit deficient epithelial Na+ channel regulation and impaired urinary Na+ conservation.

Authors:  Viktor N Tomilin; Kyrylo Pyrshev; Anna Stavniichuk; Naghmeh Hassanzadeh Khayyat; Guohui Ren; Oleg Zaika; Sherif Khedr; Alexander Staruschenko; Fang C Mei; Xiaodong Cheng; Oleh Pochynyuk
Journal:  JCI Insight       Date:  2022-02-08

Review 4.  Epac: A Promising Therapeutic Target for Vascular Diseases: A Review.

Authors:  Yunfeng Pan; Jia Liu; Jiahui Ren; Yun Luo; Xiaobo Sun
Journal:  Front Pharmacol       Date:  2022-07-14       Impact factor: 5.988

Review 5.  Phosphoproteomic Identification of Vasopressin/cAMP/Protein Kinase A-Dependent Signaling in Kidney.

Authors:  Karim Salhadar; Allanah Matthews; Viswanathan Raghuram; Kavee Limbutara; Chin-Rang Yang; Arnab Datta; Chung-Lin Chou; Mark A Knepper
Journal:  Mol Pharmacol       Date:  2020-04-03       Impact factor: 4.436

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.